Twist Bioscience Corp (TWST) Financials
$124.72
$-3.99
(-3.10%)
As on 04-Sep-2026 16:00EDT
Market cap
$8,211 Mln
Revenue (TTM)
$432 Mln
P/E Ratio
--
P/B Ratio
19
Div. Yield
0 %
Income Statement ($ Mln) |
TTM | Sep-25 | Sep-24 | Sep-23 | Sep-22 | Sep-21 | Sep-20 | Sep-19 | Sep-18 | Sep-17 | Sep-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
431.80
|
376.57
|
312.97
|
245.11
|
203.57
|
132.33
|
|
|
|
|
|
|
Cost of Revenue
|
207.41
|
185.57
|
179.63
|
155.38
|
119.33
|
80.62
|
|
|
|
|
|
|
Gross Profit
|
224.39
|
191.00
|
133.35
|
89.73
|
84.24
|
51.71
|
|
|
|
|
|
|
Operating Expenses
|
362.16
|
327.26
|
354.18
|
306.89
|
333.26
|
204.44
|
|
|
|
|
|
|
Operating Profit (EBIT)
|
-137.77
|
-136.26
|
-220.83
|
-217.16
|
-249.02
|
-152.73
|
|
|
|
|
|
|
Other Income
|
--
|
--
|
--
|
--
|
6.58
|
-0.94
|
|
|
|
|
|
|
Profit before Tax
|
-135.85
|
-76.95
|
-208.17
|
-203.47
|
-228.27
|
-154.03
|
|
|
|
|
|
|
Provision for Tax
|
0.24
|
0.72
|
0.56
|
1.15
|
-10.41
|
-1.93
|
|
|
|
|
|
|
Profit after Tax (Net Income)
|
-136.72
|
-77.67
|
-208.73
|
-204.62
|
-217.86
|
-152.10
|
|
|
|
|
|
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Consolidated Profit
|
--
|
--
|
--
|
--
|
-217.86
|
-152.10
|
|
|
|
|
|
Liabilities ($ Mln) |
TTM | Sep-25 | Sep-24 | Sep-23 | Sep-22 | Sep-21 | Sep-20 | Sep-19 | Sep-18 | Sep-17 | Sep-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
445.74
|
472.96
|
472.69
|
623.43
|
789.39
|
580.82
|
|
|
|
|
|
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Non-Current Liabilities
|
106.44
|
77.50
|
70.63
|
79.65
|
81.33
|
58.22
|
|
|
|
|
|
|
Current Liabilities
|
120.26
|
91.41
|
71.01
|
73.32
|
90.66
|
63.05
|
|
|
|
|
|
|
Total Liabilities
|
792.69
|
641.86
|
614.32
|
776.40
|
961.38
|
702.10
|
|
|
|
|
|
Assets ($ Mln) |
TTM | Sep-25 | Sep-24 | Sep-23 | Sep-22 | Sep-21 | Sep-20 | Sep-19 | Sep-18 | Sep-17 | Sep-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
351.14
|
308.90
|
267.55
|
352.15
|
364.90
|
155.60
|
|
|
|
|
|
|
Current Assets
|
321.30
|
332.97
|
346.78
|
424.26
|
596.48
|
546.50
|
|
|
|
|
|
|
Total Assets
|
792.69
|
641.86
|
614.32
|
776.40
|
961.38
|
702.10
|
|
|
|
|
|
|
Total Debt*
|
93.59
|
137.32
|
85.03
|
94.07
|
94.91
|
62.92
|
|
|
|
|
|
|
Net Current Assets
|
201.04
|
241.56
|
275.77
|
350.93
|
505.82
|
483.44
|
|
|
|
|
|
Cashflow ($ Mln) |
TTM | Sep-25 | Sep-24 | Sep-23 | Sep-22 | Sep-21 | Sep-20 | Sep-19 | Sep-18 | Sep-17 | Sep-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
-47.63
|
-64.09
|
-142.47
|
-124.39
|
-112.24
|
|
|
|
|
|
|
Cash Flow from Investing Activities
|
--
|
-24.76
|
-3.07
|
50.61
|
-232.93
|
156.16
|
|
|
|
|
|
|
Cash from Financing Activities
|
--
|
28.54
|
6.89
|
0.91
|
270.53
|
329.18
|
|
|
|
|
|
|
Net Cash Inflow / Outflow
|
--
|
--
|
--
|
--
|
-86.78
|
373.09
|
|
|
|
|
|
Financials Ratios |
TTM | Sep-25 | Sep-24 | Sep-23 | Sep-22 | Sep-21 | Sep-20 | Sep-19 | Sep-18 | Sep-17 | Sep-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS ($)
|
-2.22
|
-1.29
|
-3.60
|
-3.57
|
-3.87
|
-3.08
|
|
|
|
|
|
|
Cash EPS ($)
|
-2.16
|
-0.87
|
-3.06
|
-3.06
|
-3.58
|
-2.88
|
|
|
|
|
|
|
Adjusted Book Value ($)
|
7.11
|
7.83
|
8.15
|
10.88
|
14.03
|
11.77
|
|
|
|
|
|
|
Dividend per Share ($)
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Cash Flow per Share ($)
|
--
|
-0.79
|
-1.10
|
-2.49
|
-2.21
|
-2.27
|
|
|
|
|
|
|
Free Cash Flow per Share ($)
|
--
|
-1.25
|
-1.19
|
-2.97
|
-4.02
|
-2.82
|
|
|
|
|
|
Profitability Ratios |
TTM | Sep-25 | Sep-24 | Sep-23 | Sep-22 | Sep-21 | Sep-20 | Sep-19 | Sep-18 | Sep-17 | Sep-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
-13.30
|
-32.74
|
-25.55
|
-28.52
|
-29.94
|
|
|
|
|
|
|
ROE (%)
|
-30.32
|
-16.43
|
-38.08
|
-28.97
|
-31.80
|
-33.17
|
|
|
|
|
|
|
ROA (%)
|
-17.95
|
-12.37
|
-30.02
|
-23.55
|
-26.19
|
-27.63
|
|
|
|
|
|
|
EBIT Margin (%)
|
-30.84
|
-20.43
|
-66.50
|
-83.01
|
-122.33
|
-116.12
|
|
|
|
|
|
|
Net Margin (%)
|
-31.66
|
-20.63
|
-66.69
|
-83.48
|
-103.67
|
-115.75
|
|
|
|
|
|
|
Cash Profit Margin (%)
|
0.00
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
Growth Ratios |
TTM | Sep-25 | Sep-24 | Sep-23 | Sep-22 | Sep-21 | Sep-20 | Sep-19 | Sep-18 | Sep-17 | Sep-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
19.19
|
0.20
|
0.28
|
0.20
|
0.54
|
0.47
|
|
|
|
|
|
|
EBIT Growth (%)
|
-57.38
|
63.03
|
-2.30
|
18.30
|
-62.06
|
-10.74
|
|
|
|
|
|
|
Net Profit Growth (%)
|
-60.49
|
62.79
|
-2.01
|
6.08
|
-43.24
|
-8.70
|
|
|
|
|
|
|
EPS Growth (%)
|
-52.59
|
0.64
|
-0.01
|
0.08
|
-0.26
|
0.01
|
|
|
|
|
|
|
Book Value Growth (%)
|
-8.64
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
Valuation Ratios |
TTM | Sep-25 | Sep-24 | Sep-23 | Sep-22 | Sep-21 | Sep-20 | Sep-19 | Sep-18 | Sep-17 | Sep-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
--
|
-21.89
|
-12.56
|
-5.67
|
-9.10
|
-34.71
|
|
|
|
|
|
|
Price / Book Value
|
19.00
|
3.60
|
5.55
|
1.86
|
2.51
|
9.09
|
|
|
|
|
|
|
Dividend Yield (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
EV/EBITDA
|
-35.26
|
-30.81
|
-13.75
|
-5.27
|
-6.37
|
-33.80
|
|
|
|
|
|
|
Close Price ($)
|
102.88
|
28.14
|
45.18
|
20.26
|
35.24
|
106.97
|
|
|
|
|
|
|
High Price ($)
|
104.23
|
55.33
|
60.90
|
40.50
|
139.99
|
214.07
|
|
|
|
|
|
|
Low Price ($)
|
23.30
|
24.07
|
14.42
|
11.46
|
25.07
|
74.25
|
|
|
|
|
|
|
Market Cap ($ Cr)
|
8,210.62
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
Solvency Ratios |
TTM | Sep-25 | Sep-24 | Sep-23 | Sep-22 | Sep-21 | Sep-20 | Sep-19 | Sep-18 | Sep-17 | Sep-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
--
|
0.29
|
0.18
|
0.15
|
0.12
|
0.11
|
|
|
|
|
|
|
Short term debt to equity ratio
|
0.02
|
0.03
|
0.03
|
0.02
|
0.02
|
0.02
|
|
|
|
|
|
|
Current Ratio
|
2.67
|
3.64
|
4.88
|
5.79
|
6.58
|
8.67
|
|
|
|
|
|
|
Quick Ratio
|
2.38
|
3.33
|
4.54
|
5.35
|
6.15
|
8.16
|
|
|
|
|
|
|
Interest Coverage
|
--
|
--
|
-7,177.14
|
-40,692.20
|
-3,112.76
|
-418.69
|
|
|
|
|
|
Operating Efficiency Ratios |
TTM | Sep-25 | Sep-24 | Sep-23 | Sep-22 | Sep-21 | Sep-20 | Sep-19 | Sep-18 | Sep-17 | Sep-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
15.23
|
15.22
|
11.15
|
17.98
|
19.79
|
21.57
|
|
|
|
|
|
|
Asset Turnover
|
0.57
|
0.60
|
0.45
|
0.28
|
0.24
|
0.24
|
|
|
|
|
|
|
Receivable days
|
--
|
44.72
|
46.08
|
62.85
|
61.76
|
74.49
|
|
|
|
|
|
|
Inventory Days
|
--
|
51.56
|
57.08
|
83.88
|
108.82
|
99.87
|
|
|
|
|
|
|
Payable days
|
--
|
12.52
|
15.94
|
40.13
|
53.55
|
44.69
|
|
|
|
|
|
|
Cash Conversion Cycle
|
--
|
83.76
|
87.21
|
106.61
|
117.03
|
129.67
|
|
|
|
|
|
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
